Happy Capital assists WaveImplant in its crowdfunding operation
Nantes, France: March 23rd, 2021
After a first pre-seed fund raising finalized last year, and looking for investors to complete a first round of seed funding of 600k€, WAVEIMPLANT has secured the collaboration of the national crowdfunding platform HAPPY CAPITAL (https://www.happy-capital.com). The participatory financing campaign was just launched online for a target amount of 300k€.
Pascal Breton, WAVEIMPLANT’s CEO, declares: “We are enthusiastic about our collaboration with HAPPY CAPITAL who showed great interest for our project and spared no effort in the preparation of our application. We are confident in the success this operation will meet and in the collective support we will obtain to conduct the development of our medical device and position our breakthrough innovation in dental clinics”.
Philippe Gaborieau, HAPPY CAPITAL’s CEO, declares: “Dental implants represent a significative budget and anyone can face the loss of a tooth. Guarding oneself against an implant failure with the ImplantUS technology concerns many of us. WAVEIMPLANT follows the lineage of projects able to improve people’s quality of life and matches the mission we have set before ourselves.”
WAVEIMPANT, a French Medtech startup specialized in the development and commercialization of decision support medical devices, especially in the field of dental implantology, is focusing on the development of ImplantUS, a new ultrasonic medical device and fruit of the work of Guillaume Haïat’s (PhD) research team within the Laboratoire Modélisation et Simulation Multi-Échelle (MSME, UMR CNRS 8208, Créteil, France). ImplantUS allows a better monitoring of implant surgery procedures which are getting more widespread and offers a better guarantee of their success on the short, middle, and long term.
Thierry Toubiana, VP Business Development & Marketing at WaveImplant, specialist of the Medtech and dental implantology markets, declares: “The very attractive worldwide market of dental implantology currently weights €6.0 billion and follows a sustained annual growth of around 9%.” (source: In Extenso Innovation Croissance). Today, though most dental implantology professionals obviously have no interest in publishing such numbers, one must recognize that, objectively, 10% to 20% of the implants placed end up failing with highly detrimental consequences for the patients and dental surgeons. The majority of those failures are the consequence of an insufficient osseointegration of the implant and of its lack of stability. Thus, prior implant loading with the prosthesis, practitioners are looking for a precise and reliable estimate of its stability. However, the empirical or technological approaches currently used to this objective only provide mediocre solutions to the problem and leave a clear, unsatisfied, medical need to which ImplantUS will meet.